Computational prediction of Mycoplasma hominis proteins targeting in nucleus of host cell and their implication in prostate cancer etiology

Tumor Biology

Volumn 37, Issue 8, 2016, Pages 10805-10813

  Khan, Shahanavaj ^a,b   Zakariah, Mohammed ^c   Palaniappan, Sellappan ^d  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Shri Ram Group of College (SRGC)   (India)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d MALAYSIA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Malaysia)

Author keywords

Etiology; Host nucleus; In silico; Mycoplasma hominis; Prostate cancer; Protein targeting

Indexed keywords

BACTERIAL PROTEIN; PROTEOME; NUCLEAR LOCALIZATION SIGNAL;

ARTICLE; CANCER GROWTH; CELL NUCLEUS; CELLULAR DISTRIBUTION; DNA REPLICATION; GENE EXPRESSION; ISOELECTRIC POINT; MOLECULAR WEIGHT; MYCOPLASMA HOMINIS; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; APOPTOSIS; BIOLOGY; CELL CYCLE CHECKPOINT; CELL DIVISION; CHEMISTRY; COCARCINOGENESIS; DECISION TREE; DNA DAMAGE; EPITHELIUM CELL; HOST PATHOGEN INTERACTION; HUMAN; MALE; METABOLISM; MICROBIOLOGY; MYCOPLASMOSIS; NUCLEAR LOCALIZATION SIGNAL; PATHOGENICITY; PHYSIOLOGY; PROSTATIC NEOPLASMS; PROSTATITIS; SUPPORT VECTOR MACHINE;

APOPTOSIS; BACTERIAL PROTEINS; CELL CYCLE CHECKPOINTS; CELL DIVISION; CELL NUCLEUS; COCARCINOGENESIS; COMPUTATIONAL BIOLOGY; DECISION TREES; DNA DAMAGE; EPITHELIAL CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; MALE; MOLECULAR WEIGHT; MYCOPLASMA HOMINIS; MYCOPLASMA INFECTIONS; NUCLEAR LOCALIZATION SIGNALS; PROSTATIC NEOPLASMS; PROSTATITIS; PROTEOME; SUPPORT VECTOR MACHINE;

EID: 84957965195     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-016-4970-9     Document Type: Article

References (51)

1. Arthur JC, Perez-Chanona E, Muhlbauer M, Tomkovich S, Uronis JM, Fan TJ, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012;338:120–3.
2. Lanoix JP, Pluquet E, Lescure FX, Bentayeb H, Lecuyer E, Boutemy M, et al. Bacterial infection profiles in lung cancer patients with febrile neutropenia. BMC Infect Dis. 2011;11:183.
3. Barykova YA, Logunov DY, Shmarov MM, Vinarov AZ, Fiev DN, Vinarova NA, et al. Association of Mycoplasma hominis infection with prostate cancer. Oncotarget. 2011;2:289–97.
4. Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev. 1998;62:1094–156.
5. Huang S, Li JY, Wu J, Meng L, Shou CC. Mycoplasma infections and different human carcinomas. World J Gastroenterol. 2001;7:266–9.
6. Cimolai N. Do mycoplasmas cause human cancer? Can J Microbiol. 2001;47:691–7.
7. Barykova Iu A, Shmarov MM, Logunov D, Verkhovskaia LV, Aliaev Iu G, Fiev DN, et al. [Identification of Mycoplasma in patients with suspected prostate cancer]. Zh Mikrobiol Epidemiol Immunobiol 2010:81–5.
8. Lo SC, Tsai S. Mycoplasmas and human prostate cancer: an exciting but cautionary note. Oncotarget. 2011;2:352–5.
9. Feng SH, Tsai S, Rodriguez J, Lo SC. Mycoplasmal infections prevent apoptosis and induce malignant transformation of interleukin-3-dependent 32D hematopoietic cells. Mol Cell Biol. 1999;19:7995–8002.
10. Tsai S, Wear DJ, Shih JW, Lo SC. Mycoplasmas and oncogenesis: persistent infection and multistage malignant transformation. Proc Natl Acad Sci U S A. 1995;92:10197–201.
11. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG, et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer. 2007;7:256–69.
12. Sfanos KS, De Marzo AM. Prostate cancer and inflammation: the evidence. Histopathology. 2012;60:199–215.
13. Ito K. Prostate cancer in Asian men. Nat Rev Urol. 2014;11:197–212.
14. Dessi D, Delogu G, Emonte E, Catania MR, Fiori PL, Rappelli P. Long-term survival and intracellular replication of Mycoplasma hominis in Trichomonas vaginalis cells: potential role of the protozoon in transmitting bacterial infection. Infect Immun. 2005;73:1180–6.
15. Namiki K, Goodison S, Porvasnik S, Allan RW, Iczkowski KA, Urbanek C, et al. Persistent exposure to Mycoplasma induces malignant transformation of human prostate cells. PLoS One. 2009;4, e6872.
16. Apweiler R, Bairoch A, Wu CH, Barker WC, Boeckmann B, Ferro S, et al. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 2004;32:D115–9.
17. Boeckmann B, Bairoch A, Apweiler R, Blatter MC, Estreicher A, Gasteiger E, et al. The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res. 2003;31:365–70.
18. Wu CH, Yeh LS, Huang H, Arminski L, Castro-Alvear J, Chen Y, et al. The protein information resource. Nucleic Acids Res. 2003;31:345–7.
19. Consortium U. Update on activities at the Universal Protein Resource (UniProt) in 2013. Nucleic Acids Res. 2013;41:D43–7.
20. Pereyre S, Sirand-Pugnet P, Beven L, Charron A, Renaudin H, Barre A, et al. Life on arginine for Mycoplasma hominis: clues from its minimal genome and comparison with other human urogenital mycoplasmas. PLoS Genet. 2009;5, e1000677.
21. Kosugi S, Hasebe M, Tomita M, Yanagawa H. Systematic identification of cell cycle-dependent yeast nucleocytoplasmic shuttling proteins by prediction of composite motifs. Proc Natl Acad Sci U S A. 2009;106:10171–6.
22. Pierleoni A, Martelli PL, Fariselli P, Casadio R. BaCelLo: a balanced subcellular localization predictor. Bioinformatics. 2006;22:e408–16.
23. Tran EJ, Wente SR. Dynamic nuclear pore complexes: life on the edge. Cell. 2006;125:1041–53.
24. Khan S. Potential role of Escherichia coli DNA mismatch repair proteins in colon cancer. Crit Rev Oncol Hematol 2015.
25. Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell. 2006;124:823–35.
26. Sutcliffe S, Platz EA. Inflammation and prostate cancer: a focus on infections. Curr Urol Rep. 2008;9:243–9.
27. Poutahidis T, Cappelle K, Levkovich T, Lee CW, Doulberis M, Ge Z, et al. Pathogenic intestinal bacteria enhance prostate cancer development via systemic activation of immune cells in mice. PLoS One. 2013;8, e73933.
28. Huh WK, Falvo JV, Gerke LC, Carroll AS, Howson RW, Weissman JS, et al. Global analysis of protein localization in budding yeast. Nature. 2003;425:686–91.
29. Garg A, Bhasin M, Raghava GP. Support vector machine-based method for subcellular localization of human proteins using amino acid compositions, their order, and similarity search. J Biol Chem. 2005;280:14427–32.
30. Kumar M, Raghava GP. Prediction of nuclear proteins using SVM and HMM models. BMC Bioinforma. 2009;10:22.
31. Su EC, Chang JM, Cheng CW, Sung TY, Hsu WL. Prediction of nuclear proteins using nuclear translocation signals proposed by probabilistic latent semantic indexing. BMC Bioinforma. 2012;13 Suppl 17:S13.
32. Lange A, Mills RE, Lange CJ, Stewart M, Devine SE, Corbett AH. Classical nuclear localization signals: definition, function, and interaction with importin alpha. J Biol Chem. 2007;282:5101–5.
33. Kosugi S, Hasebe M, Entani T, Takayama S, Tomita M, Yanagawa H. Design of peptide inhibitors for the importin alpha/beta nuclear import pathway by activity-based profiling. Chem Biol. 2008;15:940–9.
34. Kosugi S, Hasebe M, Matsumura N, Takashima H, Miyamoto-Sato E, Tomita M, et al. Six classes of nuclear localization signals specific to different binding grooves of importin alpha. J Biol Chem. 2009;284:478–85.
35. Hopfe M, Deenen R, Degrandi D, Kohrer K, Henrich B. Host cell responses to persistent mycoplasmas—different stages in infection of HeLa cells with Mycoplasma hominis. PLoS One. 2013;8, e54219.
36. Logunov DY, Scheblyakov DV, Zubkova OV, Shmarov MM, Rakovskaya IV, Gurova KV, et al. Mycoplasma infection suppresses p53, activates NF-kappaB and cooperates with oncogenic Ras in rodent fibroblast transformation. Oncogene. 2008;27:4521–31.
37. Suzuki M, Takahashi T. Aberrant DNA replication in cancer. Mutat Res 2013; 743–744:111–7.
38. Parry L, Clarke AR. The roles of the methyl-CpG binding proteins in cancer. Genes Cancer. 2011;2:618–30.
39. Kattan Z, Marchal S, Brunner E, Ramacci C, Leroux A, Merlin JL, et al. Damaged DNA binding protein 2 plays a role in breast cancer cell growth. PLoS One. 2008;3, e2002.
40. Wu X, Zhu Z, Li W, Fu X, Su D, Fu L, et al. Chromodomain helicase DNA binding protein 5 plays a tumor suppressor role in human breast cancer. Breast Cancer Res. 2012;14:R73.
41. Maw MK, Fujimoto J, Tamaya T. Overexpression of inhibitor of DNA-binding (ID)-1 protein related to angiogenesis in tumor advancement of ovarian cancers. BMC Cancer. 2009;9:430.
42. Strickertsson JA, Desler C, Rasmussen LJ. Impact of bacterial infections on aging and cancer: impairment of DNA repair and mitochondrial function of host cells. Exp Gerontol. 2014;56:164–74.
43. Zhang B, Shih JW, Wear DJ, Tsai S, Lo SC. High-level expression of H-ras and c-myc oncogenes in mycoplasma-mediated malignant cell transformation. Proc Soc Exp Biol Med. 1997;214:359–66.
44. Yang J, Hooper WC, Phillips DJ, Tondella ML, Talkington DF. Induction of proinflammatory cytokines in human lung epithelial cells during Chlamydia pneumoniae infection. Infect Immun. 2003;71:614–20.
45. Mote Jr J, Reines D. Recognition of a human arrest site is conserved between RNA polymerase II and prokaryotic RNA polymerases. J Biol Chem. 1998;273:16843–52.
46. Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J. Transcription termination. In: In Molecular Cell Biology. New York: W.H. Freeman, 2000.
47. Garnis C, Buys TP, Lam WL. Genetic alteration and gene expression modulation during cancer progression. Mol Cancer. 2004;3:9.
48. Libermann TA, Zerbini LF. Targeting transcription factors for cancer gene therapy. Curr Gene Ther. 2006;6:17–33.
49. Riley DR, Sieber KB, Robinson KM, White JR, Ganesan A, Nourbakhsh S, et al. Bacteria-human somatic cell lateral gene transfer is enriched in cancer samples. PLoS Comput Biol. 2013;9, e1003107.
50. Dunning Hotopp JC. Horizontal gene transfer between bacteria and animals. Trends Genet. 2012;27:157–63.
51. Khan AA, Shrivastava A. Bacterial infections associated with cancer: possible implication in etiology with special reference to lateral gene transfer. Cancer Metastasis Rev. 2010;29:331–7.